Breast Cancer Research - oalib

OALib Journal期刊
ISSN: 2333-9721
费用：99美元

投递稿件

为什么选择我们？ >>

- 开源期刊

- 同行审议

- 快速出刊

- 终身存储

- 免费检索

- 免费推广

- 更多...

- 搜索引擎

Breast Cancer Research

ISSN Print: 1465-5411

ISSN Online:

主页: http://breast-cancer-research.com

分享:

Reversibility and progression in conditional transgenic mouse models of breast cancer

LA Chodosh, RB Boxer, SE Moody, BA Keister, CJ Sarkisian, JW Jang, GK Belka, CM Blakely, CP Portocarero, CJ Sterner, KL Notarfrancesco, EA Kauh

Development of a transgenic mouse line for the evaluation of the androgen receptor activity in vivo

R Attar, C Cullinan, C-P Ho, M Swerdel, J Dell, RB Rowley, DJ Bol, J Ostrowski, K Mookhtiar, M Gottardis, R Weinmann

Clinical breast cancer and estrogen

HK Chew

Pregnancy levels of estrogen prevents breast cancer

S Nandi, RC Guzman, G Thordarson, L Rajkumar

Steroid regulation of breast cancer cell proliferation

RL Sutherland

42nd Annual Meeting of the American Society for Cell Biology, San Francisco, California, USA, 14–18 December 2002

Paraic A Kenny, Aylin Rizki

BRCA2 mutation carriers, reproductive factors and breast cancer risk

Laufey Tryggvadottir, Elinborg J Olafsdottir, Sigfridur Gudlaugsdottir, Steinunn Thorlacius, Jon G Jonasson, Hrafn Tulinius, Jorunn E Eyfjord

Nuclear localization and function of polypeptide ligands and their receptors: a new paradigm for hormone specificity within the mammary gland?

Charles V Clevenger

Cytoplasmic p21WAF1/CIP1 expression is correlated with HER-2/ neu in breast cancer and is an independent predictor of prognosis

Zo？ E Winters, Russell D Leek, Mike J Bradburn, Chris J Norbury, Adrian L Harris

American Society for Clinical Oncology 39th Annual Meeting, Chicago, Illinois, USA, 31 May to 3 June 2003: Breast cancer neoadjuvant and adjuvant chemotherapy – prognostic and predictive markers

Helena Earl

Correlation of expression of BP1, a homeobox gene, with estrogen receptor status in breast cancer

Sidney W Fu, Arnold Schwartz, Holly Stevenson, Joseph J Pinzone, Gregory J Davenport, Jan M Orenstein, Peter Gutierrez, Samuel J Simmens, Jessy Abraham, Indira Poola, Dietrich A Stephan, Patricia E Berg

IARC Handbooks of Cancer Prevention, Volume 7: Breast Cancer Screening

Robert A Smith

A quiet revolution in the endocrine therapy of breast cancer

V Craig Jordan

The diagnosis and management of pre-invasive breast disease: Promise of new technologies in understanding pre-invasive breast lesions

Stefanie S Jeffrey, Jonathan R Pollack

The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions

Jorge S Reis-Filho, Sunil R Lakhani

The diagnosis and management of pre-invasive breast disease: Problems associated with management of pre-invasive lesions

Anand D Purushotham

Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status

Niklas Loman, Anna Bladstr？m, Oskar Johannsson, ？ke Borg, H？kan Olsson

Health food store recommendations: implications for breast cancer patients

Edward Mills, Edzard Ernst, Rana Singh, Cory Ross, Kumanan Wilson

Breast cancer patients with bone metastases are characterised by increased levels of nonisomerised type I collagen fragments

Paul Andreas Compare Cloos, Stephan Christgau, Nina Lyubimova, Jean-Jacques Body, Per Qvist, Claus Christiansen

Risk factors for breast cancer in a population with high incidence rates

Margaret Wrensch, Terri Chew, Georgianna Farren, Janice Barlow, Flavia Belli, Christina Clarke, Christine A Erdmann, Marion Lee, Michelle Moghadassi, Roni Peskin-Mentzer, Charles P Quesenberry, Virginia Souders-Mason, Linda Spence, Marisa Suzuki, Mary Gould

Models of breast cancer: quo vadis, animal modeling?

Kay-Uwe Wagner

Models of breast cancer: is merging human and animal models the future?

Jong B Kim, Michael J O'Hare, Robert Stein

Expanding the therapeutic repertoire of epidermal growth factor receptor blockade: radiosensitization

Julia MW Gee, Robert I Nicholson

Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast

Malathy PV Shekhar, Robert Pauley, Gloria Heppner

Inflammatory breast cancer: Relationship between growth factor signaling and motility in aggressive cancers

Kenneth L van Golen

The role of androgens and polymorphisms in the androgen receptor in the epidemiology of breast cancer

Elizabeth O Lillie, Leslie Bernstein, Giske Ursin

The thyroid, iodine and breast cancer

Peter PA Smyth

Expression of androgen receptor and prostate-specific antigen in male breast carcinoma

Noman Kidwai, Yun Gong, Xiaoping Sun, Charuhas G Deshpande, Anjana V Yeldandi, M Sambasiva Rao, Sunil Badve

The diagnosis and management of pre-invasive breast disease: Ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH) – current definitions and classification

Sarah E Pinder, Ian O Ellis

Oestrogen exposure and breast cancer risk

Ruth C Travis, Timothy J Key

Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase–polymerase chain reaction

Ron Greenberg, Ignat Schwartz, Yehuda Skornick, Ofer Kaplan

A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment

Mark E Robson, Pierre O Chappuis, Jaya Satagopan, Nora Wong, Jeff Boyd, John R Goffin, Clifford Hudis, David Roberge, Larry Norton, Louis R Bégin, Kenneth Offit, William D Foulkes

Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments

Lakshmanaswamy Rajkumar, Raphael C Guzman, Jason Yang, Gudmundur Thordarson, Frank Talamantes, Satyabrata Nandi

AACR Special Conference: Advances in Breast Cancer Research – Genetics, Biology, and Clinical Implications, Huntington Beach, California, USA, 8–12 October 2003

Alana L Welm

aHIF but not HIF-1α transcript is a poor prognostic marker in human breast cancer

Anne Cayre, Fabrice Rossignol, Eric Clottes, Frédérique Penault-Llorca

Can the stroma provide the clue to the cellular basis for mammographic density?

Ruth Warren, Sunil R Lakhani

Inflammatory breast cancer: Vasculogenic mimicry and its hemodynamics ofan inflammatory breast cancer xenograft model

Kazuo Shirakawa, Hisataka Kobayashi, Jun Sobajima, Daijo Hashimoto, Atsushi Shimizu, Hiro Wakasugi

Prevention of breast cancer by recapitulation of pregnancy hormone levels

Debra A Tonetti

Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

Jimmie E Fata, Zena Werb, Mina J Bissell

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy

Wenlin Shao, Myles Brown

Log odds of carrying an Ancestral Mutation in BRCA1 or BRCA2 for a Defined personal and family history in an Ashkenazi Jewish woman (LAMBDA)

Carmel Apicella, Lesley Andrews, Shirley V Hodgson, Sheila A Fisher, Cathryn M Lewis, Ellen Solomon, Katherine Tucker, Michael Friedlander, Agnes Bankier, Melissa C Southey, Deon J Venter, John L Hopper

Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?

D Gareth Evans, Anthony Howell

Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion

Yan-gao Man, Lisa Tai, Ross Barner, Russell Vang, Jeffrey S Saenger, Kris M Shekitka, Gary L Bratthauer, Darren T Wheeler, Chang Y Liang, Tuyethoa N Vinh, Brian L Strauss

E-cadherin expression in primary carcinomas of the breast and its distant metastases

Paul J Kowalski, Mark A Rubin, Celina G Kleer

Familial breast cancer and the hCHK2 1100delC mutation: assessing cancer risk

Jenny Varley, Daniel A Haber

Transforming growth factor beta-regulated gene expression in a mouse mammary gland epithelial cell line

Lu Xie, Brian K Law, Mary E Aakre, Mary Edgerton, Yu Shyr, Neil A Bhowmick, Harold L Moses

Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer

Renee M Moadel, Andrew V Nguyen, Elaine Y Lin, Ping Lu, Joseph Mani, M Donald Blaufox, Jeffrey W Pollard, Ekaterina Dadachova

Breast Cancer Therapy Annual – today's drug treatment of cancer?

David Cameron

Quantitative determination, by real-time reverse transcription polymerase chain reaction, of aromatase mRNA in invasive ductal carcinoma of the breast

Zhenhuan Zhang, Hiroko Yamashita, Tatsuya Toyama, Yoko Omoto, Hiroshi Sugiura, Yasuo Hara, Xueqing Wu, Shunzo Kobayashi, Hirotaka Iwase

Interleukin-2 and its receptor complex (α, β and γ chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative study

Ignacio García-Tu？ón, Mónica Ricote, Antonio Ruiz, Benito Fraile, Ricardo Paniagua, Mar Royuela

©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705